Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Operating Margin for Titan Pharmaceuticals (TTNP)
Operating Margin as of May 2024 (TTM): -2,570.78%
According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -2,570.78%. At the end of 2021 the company had an Operating Margin of -575.10%.
Operating Margin history for Titan Pharmaceuticals from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -575.10% | 275.63% |
| 2020 | -153.10% | -66.41% |
| 2019 | -455.77% | 198.58% |
| 2018 | -152.65% | -97.71% |
| 2017 | -6,654.42% | -19622.65% |
| 2016 | 34.09% | -105.05% |
| 2015 | -674.99% | 924.13% |
| 2014 | -65.91% | -171.13% |
| 2013 | 92.65% | -143.44% |
| 2012 | -213.29% | -17.41% |
| 2011 | -258.26% | 332.63% |
| 2010 | -59.69% | -99.19% |
| 2009 | -7,360.76% | |
| 2007 | -76,804.17% | 49.43% |
| 2006 | -51,396.88% | 98.44% |
| 2005 | -25,900.00% | -68.66% |
| 2004 | -82,648.39% | 169.66% |
| 2003 | -30,649.44% | 2669.68% |
| 2002 | -1,106.60% | 109.5% |
| 2001 | -528.22% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.89% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -100.67% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | 6.23% | -100.24% | 🇺🇸 USA |
 Repligen
RGEN | 27.34% | -101.06% | 🇺🇸 USA |
 MediciNova MNOV | -250.93% | -90.24% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -1,520.92% | -40.84% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.